Alendronate to prevent pelvic bone fractures during cervical cancer treatment
Treatments studied
Part of Cancer, Women’s health & pregnancy clinical trials.
This trial tests whether the drug alendronate can help prevent stress fractures (small breaks) in the pelvic bones of women with cervical cancer who are getting chemotherapy and radiation. It aims to reduce bone pain and improve bone health during treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older.
- You must have cervical cancer that has not spread to other organs, at a stage between IB2 and IVA.
- You must be planning to receive chemotherapy and radiation therapy, either as your main treatment or after surgery.
- You must not have a history of osteoporosis or have taken bone-strengthening medications before.
- You must have had a recent scan (within the last 3 months) showing no cancer in your bones.
- You must not have had radiation therapy to your pelvic area before.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study wants to see if it is safe for postmenopausal women with osteoporosis to stop taking Alendronate after a long period of treatment without any new fractures. If you have been on Alendronate for a while and have stayed fracture-free, you may be able to take a break from the medicine.
This trial tests a combination of vitamin K, D-chiro inositol, and α-lactalbumin to help maintain bone strength in women with breast cancer who are on hormone therapy and have low vitamin D. It aims to see if these supplements improve bone health while you take a standard bone medication (alendronate).
This trial studies whether doing a structured bone-focused exercise program, taking alendronate (a medication that slows bone loss), and making a calorie-reducing diet can improve bone strength in people with low bone density. It also compares different combinations to see what helps most and is safest for you.
This trial tests whether giving radiation therapy to spots where cancer has spread to the bone can prevent future bone problems like fractures. It's for people who have a few bone metastases that aren't causing severe pain yet.
This trial tests if the drug alendronate can help heal bone damage caused by sickle cell disease. It may be an option if you have this bone problem and are between 18 and 80 years old.
This trial is testing a combination of standard chemotherapy and radiation delivered to the pelvis, followed by an internal radiation treatment guided by CT scans. The goal is to improve treatment for locally advanced cervical cancer while potentially reducing side effects.
Hear when a new Cervix Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.